The Antibody Engineering and Development team at Velabs Therapeutics focuses on designing, optimizing, and characterizing novel antibodies using advanced microfluidics technologies. This multidisciplinary team collaborates on target discovery and functional screening to accelerate the development of effective therapeutic candidates, ensuring efficient workflows and innovative solutions in antibody research.
Anja Schreiber
Scientist New Developments
Anna Pryszlak
Director Antibody Screening
Christine Köhler
Head Of Antibody Engineering
Helga Grötsch
Scientist
Jawad Iqbal
Scientist Target Discovery
Jessica Seib
Junior Scientist
Laura Vidoni
Scientific Assistant
Sadat Hasan
Microfluidics Scientist
Sebastian Łatwiel
Antibody Engineer